featured
Dupilumab Reduces Absenteeism in Patients With Moderate-to-Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dupilumab Reduces Absenteeism in Patients With Moderate-to-Severe Atopic Dermatitis: Pooled Results From the LIBERTY AD SOLO Clinical Trials
J Am Acad Dermatol 2020 Jun 03;[EPub Ahead of Print], M de Bruin-Weller, EL Simpson, M Cork, Z Chen, J Msihid, C Taniou, L Eckert, A Gadkari, G Bégo-Le BagousseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.